(Q46879488)

26 December 2017

title

Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia (English)

1 reference

26 December 2017

1 reference

3

Sylvie Trottier

1 reference

26 December 2017

1

Jean-Guy Baril

1 reference

26 December 2017

author name string

Colin M Kovacs

2

1 reference

26 December 2017

Ghislaine Roederer

4

1 reference

26 December 2017

Alain Y Martel

5

1 reference

26 December 2017

Nabil Ackad

6

1 reference

26 December 2017

Theodoro Koulis

7

1 reference

26 December 2017

John S Sampalis

8

1 reference

26 December 2017

publication date

1 November 2007

1 reference

26 December 2017

published in

HIV Clinical Trials

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

400-411

1 reference

26 December 2017

Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection

cites work

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Incidence of hyperlipidaemia in a cohort of 212 HIV-infected patients receiving a protease inhibitor-based antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Issues in hyperlipidemic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Evaluation and management of dyslipidemia in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Fish consumption, fish oil, lipids, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT0806-400

21 January 2018

Identifiers

DOI

10.1310/HCT0806-400

1 reference

26 December 2017

PubMed ID

18042505

1 reference

26 December 2017